Ads
related to: lipoprotein a treatment- Co-Pay Program
Resources
to Support Your Patients
- Safety
Safety Profile - Learn About
Adverse Patient Reactions
- Dosing & Administration
Efficacy, Safety, and Dosing
Information for HCPs
- MOA
Mechanism of Action -
Watch A Video To Learn More
- Patient Identification
View a Patient Profile
to Learn More
- Resources
More Information
For Your Practice
- Co-Pay Program
Search results
How do you lower your LDL cholesterol? Diet and other remedies
Medical News Today· 3 days agoDietary and lifestyle changes may help lower low-density lipoprotein (LDL) cholesterol levels. High...
Roche Blood Test for Lp(a) Designated Breakthrough Device
Medscape· 2 days agoA blood test that measures lipoprotein(a) [Lp(a)] has received breakthrough device designation from...
3 Reasons to Buy CRISPR Therapeutics Stock Like There's No Tomorrow
Motley Fool via Yahoo Finance· 4 days agoAs more treatment centers open, more patients will be eligible for treatment, and sales will start...
Chasing Merck, AstraZeneca's PCSK9 inhibitor lowers cholesterol in phase 1 test
FierceBiotech· 1 day agoAstraZeneca’s small molecule lowered levels of “bad” cholesterol by more than half in patients who...
The heart health risks for midlife women – and how to beat them
The Telegraph via Yahoo News· 9 hours agoWhen, in her late 40s, Rebecca Hutchinson started having hot flushes and dizzy spells, she thought...
Promising results for hyperlipidemia treatment reduce risk of cardiovascular events
Medical Xpress· 2 days agoThe results, published in the latest edition of the New England Journal of Medicine, demonstrate how the drug plozasiran works by targeting ApoC3, which is a key regulator ...
Hemorrhagic Stroke: How to Spot and Prevent It
Verywell Health via Yahoo News· 5 days agoOften, brain imaging is repeated days after a hemorrhagic stroke to assess whether bleeding has slowed and edema is subsiding. Emergency Treatment for &...
RNA Inhibitor Is Shown Safe and Effective in Reduc | Newswise
Newswise· 2 days agoNewswise — (New York, NY - May 29, 2024) – A small interfering RNA (siRNA) investigational therapy...
Arrowhead's much-anticipated cholesterol drug hits the mark again in phase 2 hyperlipidemia trial
FierceBiotech· 2 days agoThe company presented results from the midstage MUIR study of plozasiran at the 92nd European...
